Literature DB >> 17702273

REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.

Valérie Cochen De Cock1, Annie Lannuzel, Stéphane Verhaeghe, Emmanuel Roze, Merle Ruberg, Jean Philippe Derenne, Jean Claude Willer, Marie Vidailhet, Isabelle Arnulf.   

Abstract

STUDY
OBJECTIVE: To describe sleep characteristics and rapid eye movement (REM) sleep behavior disorder in patients with Guadeloupean atypical parkinsonism (Gd-PSP), a tauopathy resembling progressive supranuclear palsy that mainly affects the midbrain. It is possibly caused by the ingestion of sour sop (corossol), a tropical fruit containing acetogenins, which are mitochondrial poisons.
DESIGN: Sleep interview, motor and cognitive tests, and overnight videopolysomnography. PATIENTS: Thirty-six age-, sex-, disease-duration- and disability-matched patients with Gd-PSP (n = 9), progressive supranuclear palsy (a tauopathy, n = 9), Parkinson disease (a synucleinopathy, n = 9) and controls (n = 9). SETTINGS: Tertiary-care academic hospital.
RESULTS: REM sleep behavior disorder was found in 78% patients with Gd-PSP (43% of patients reported having this disorder several years before the onset of parkinsonism), 44% of patients with idiopathic Parkinson disease, 33% of patients with progressive supranuclear palsy, and no controls. The percentage of muscle activity during REM sleep was greater in patients with Gd-PSP than in controls (limb muscle activity, 8.3%+/-8.7% vs 0.1%+/- 0.2%; chin muscle activity, 24.3%+/- 23.7% vs 0.7%+/-2.0%) but similar to that of other patient groups. The latency and percentage of REM sleep were similar in patients with Gd-PSP, patients with Parkinson disease, and controls, whereas patients with progressive supranuclear palsy had delayed and shortened REM sleep.
CONCLUSION: Although Gd-PSP is a tauopathy, most patients experience REM sleep behavior disorder. This suggests that the location of neuronal loss or dysfunction in the midbrain, rather than the protein comprising the histologic lesions (synuclein versus tau aggregation), is responsible for suppressing muscle atonia during REM sleep. Subjects with idiopathic REM sleep behavior disorder should avoid eating sour sop.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702273      PMCID: PMC1978393          DOI: 10.1093/sleep/30.8.1026

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  34 in total

1.  Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.

Authors:  D Caparros-Lefebvre; A Elbaz
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

Review 2.  Executive mechanisms of paradoxical sleep.

Authors:  K Sakai
Journal:  Arch Ital Biol       Date:  1988-10       Impact factor: 1.000

3.  A putative flip-flop switch for control of REM sleep.

Authors:  Jun Lu; David Sherman; Marshall Devor; Clifford B Saper
Journal:  Nature       Date:  2006-05-10       Impact factor: 49.962

4.  REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease.

Authors:  Jean-François Gagnon; Dominique Petit; Maria Livia Fantini; Sylvie Rompré; Serge Gauthier; Michel Panisset; Alain Robillard; Jacques Montplaisir
Journal:  Sleep       Date:  2006-10       Impact factor: 5.849

5.  Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.

Authors:  Dominique Caparros-Lefebvre; Nicolas Sergeant; Andrew Lees; Agnes Camuzat; Susan Daniel; Annie Lannuzel; Alexis Brice; Eduardo Tolosa; Andre Delacourte; Charles Duyckaerts
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

6.  Vigilance states in a parkinsonian model, the MPTP mouse.

Authors:  Christelle Monaca; Charlotte Laloux; Jean-Marie Jacquesson; Patrick Gelé; Xavier Maréchal; Régis Bordet; Alain Destée; Philippe Derambure
Journal:  Eur J Neurosci       Date:  2004-11       Impact factor: 3.386

7.  Sleep and quantitative EEG in patients with progressive supranuclear palsy.

Authors:  J Montplaisir; D Petit; A Décary; H Masson; M A Bédard; M Panisset; G Rémillard; S Gauthier
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred.

Authors:  Bradley F Boeve; Siong-Chi Lin; Audrey Strongosky; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Arch Neurol       Date:  2006-02

10.  [Sleep abnormalities and evoked potentials (VEP-BAER-SEP) in progressive supranuclear palsy].

Authors:  F Laffont; J M Leger; A Penicaud; M Minz; P Chaine; P Bertrand; H P Cathala
Journal:  Neurophysiol Clin       Date:  1988-06       Impact factor: 3.734

View more
  13 in total

Review 1.  Diagnostic tools for REM sleep behavior disorder.

Authors:  Ariel B Neikrug; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2011-12-14       Impact factor: 11.609

Review 2.  REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management.

Authors:  Lynn Marie Trotti
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

Review 3.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

Review 4.  Clinical trials in REM sleep behavioural disorder: challenges and opportunities.

Authors:  Aleksandar Videnovic; Yo-El S Ju; Isabelle Arnulf; Valérie Cochen-De Cock; Birgit Högl; Dieter Kunz; Federica Provini; Pietro-Luca Ratti; Mya C Schiess; Carlos H Schenck; Claudia Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-13       Impact factor: 10.154

Review 5.  REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions.

Authors:  Bradley F Boeve
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 6.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

7.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

8.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

Review 9.  Parasomnias: an updated review.

Authors:  Michael J Howell
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

10.  Morbidities in rapid eye movement sleep behavior disorder.

Authors:  Poul Jennum; Geert Mayer; Yo-El Ju; Ron Postuma
Journal:  Sleep Med       Date:  2013-01-29       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.